Latest Breaking News On - Kro stock - Page 1 : comparemela.com

SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) Hagens Berman urges Akero Therapeutics, Inc. (NASDAQ: AKRO) investors who suffered substantial losses to.

Reed kathreinHagens bermanAkero therapeutics incAkero therapeuticsPlaintiff deadlineSecurities fraud class actionHagens berman sobol shapiro llpKro lawsuitKro class actionKro investor fraudKro securities fraudKro securities class actionKro investorKro stockLass action